A technology called tissue nanotransfection uses nanochips to reprogram skin cells in a damaged area, allowing regeneration of any kind of cell needed for medical treatment, even precursors for vascular tissue or organs. An Ohio State University team that tested the technology in pigs and mice reported a 98% success rate, and human trials are expected next year.
Novel tech can regenerate damaged tissue from tiny patch
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.